Israeli startups Collplant and Stratasys have commenced a pre-clinical study to test the ability of their 3D-printed implants (see here previously) to promote the growth of natural tissue and completely degrade over time. It may be an alternative to reconstructive … Continue reading →

Israeli startups Stratasys (see here previously) and CollPlant (see here previously) are jointly to create human tissues and organs. They will use Stratasys’ P3 bioprinter and CollPlant’s rh-Collagen-based bioinks. The first project will be to produce reconstructive implants. https://ir.collplant.com/news-events/press-releases/detail/144/stratasys-and-collplant-unite-technologies-to-transform